Company page

Corcept Therapeutics Incorporated

Corcept Therapeutics Incorporated, trading under the ticker CORT, is a public company based in the United States with a market capitalization of approximately $8.58 billion. The company focuses on developing and commercializing innovative treatments for patients with severe metabolic and psychiatric disorders. Corcept's commitment to advancing healthcare solutions positions it as a significant player in the biopharmaceutical industry.